5905. Dermaden.   ,(F.D.C. No. 42782.    S. No. 42-410 P.)
QUANTITY:   2 display ctns., each containing 8   120-cc. btls., and 16   240-cc.
btls., at Seattle, Wash. 
SHIPPED :   9-22-58, from Portland, Oreg., by Consumer Drug Corp. 
LABEL IN PAST:    (Btl.)  "Dermaden * * * A Penicillin-Like Skin Application
* * * Antibiotic-Anaesthetic-Fungicidal. Distributed by Consumer Drug Cor- 
poration, Portland, Oregon * * * Contains .01% Diatrex (Disodium-ethylene- 
diamine-tetracetate), 1% Benzocaine, 1% Salicylic Acid, 1% Resorcin, 2% 
Methyl Salicylate, 0.5% Phenol, 0.02% Tyrothricin in special greaseless, non- 
staining, Ultra-Microscopic Base"; (display ctn.) "Dermaden-Fights Fiery 
Itching, Promotes Healing, Combats Infection * * ?* Contains U-M-B A New 
Concept in "Sustained Action" Skin Medication * * * in addition to its anti- 
septic content, the very base of Dermaden is anti-bacterial and absorbs toxins
* * * Product of Consumer Drug Corporation." 
LIBELED :   About 1-15-59, W. Dist. Wash.
(
CHARGE: 502(a)-when shipped, the labeling contained false and misleading 
representations that the article was an adequate and effective treatment for 
inflamed conditions and common skin disorders, including eczema, allergies, 
nervous itch, and fungus infections; that the action of the article was essentially 
similar to that of penicillin; and that it represented a new concept in sustained 
action skin medication; 502(e) (2)-the label failed to bear the common or 
usual name of each active ingredient since the labeling of the article represented 
that the ointment base was itself an active ingredient and the label did not 
disclose the identity of the ointment base or list its ingredients; and 502(f) 
(2)-the labeling failed to bear such adequate warnings against unsafe dosage 
or methods or duration of administration in such manner and form as are 
necessary for the protection of users since its labeling failed to bear a warning 
in essentially the following form: "Warning: Not for prolonged use. Do not 
apply to large areas of the body. If redness, irritation, or swelling of the skin 
develops or pain persists or increases, discontinue use and consult a physician. 
Do not use in the eyes."
DISPOSITION :   5-25-59.   Default-destruction.